Nanocarrier Based Drug Delivery Of Biologics: Enabling The Rise Of Biosimilars In India

Biologics are redefining modern therapies but the clinical efficacy is hampered by bioavailability, stability and delivery issues. Nanocarrier based drug delivery presently shows new opportunities to optimize targeted drug delivery, immunogenicity and pharmacokinetics. In India, for enhancing treatment outcomes and to improve accessibility with clinical efficacy, researchers are integrating nanotechnology and biosimilars emerging transformative approaches. Advances in polymeric and inorganic and lipid based nanocarrier systems have remarkably improved the delivery of biologics by addressing challenges such as low bioavailability, targeted delivery and poor stability limitations. These advancements are making a strategic shift from conventional towards the high value biopharmaceutical. Further, they support cost-effective therapies options, promote innovation and strengthen India’s competitiveness in the global pharmaceutical sector.